Related Experiment Video
Updated: Aug 27, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Emerging and re-emerging fungal threats in Africa
Rachael Dangarembizi1,2,3, Sean Wasserman4,5, Jennifer Claire Hoving3,4,6
1Division of Physiological Sciences, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Abstract:
The emergence of deadly fungal infections in Africa is primarily driven by a disproportionately high burden of human immunodeficiency virus (HIV) infections, lack of access to quality health care, and the unavailability of effective antifungal drugs. Immunocompromised people in Africa are therefore at high risk of infection from opportunistic fungal pathogens such as Cryptococcus neoformans and Pneumocystis jirovecii, which are associated with high morbidity, mortality, and related socioeconomic impacts. Other emerging fungal threats include Emergomyces spp., Histoplasma spp., Blastomyces spp., and healthcare-associated multi-drug resistant Candida auris. Socioeconomic development and the Covid-19 pandemic may influence shifts in epidemiology of invasive fungal diseases on the continent. This review discusses the epidemiology, clinical manifestations, and current management strategies available for these emerging fungal diseases in Africa. We also discuss gaps in knowledge, policy, and research to inform future efforts at managing these fungal threats.
Insights
Deadly fungal infections in Africa are rising due to HIV, poor healthcare, and few antifungal drugs. This review covers emerging fungal threats, their impact, and management strategies to improve patient outcomes.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Public Health in Africa
Background:
- High burden of human immunodeficiency virus (HIV) infections compromises immunity, increasing susceptibility to opportunistic fungal pathogens.
- Limited access to quality healthcare and a scarcity of effective antifungal medications exacerbate the risk and impact of fungal diseases in Africa.
- Emerging fungal threats, including Emergomyces spp., Histoplasma spp., Blastomyces spp., and multidrug-resistant Candida auris, pose significant public health challenges.
Purpose of the Study:
- To review the epidemiology and clinical manifestations of emerging fungal diseases in Africa.
- To discuss current management strategies for invasive fungal infections on the continent.
- To identify knowledge, policy, and research gaps to guide future interventions.
Main Methods:
- Literature review of emerging fungal diseases in Africa.
- Analysis of epidemiological trends and clinical presentations.
- Evaluation of current treatment guidelines and antifungal drug availability.
Main Results:
- Cryptococcus neoformans and Pneumocystis jirovecii are significant opportunistic pathogens in immunocompromised individuals.
- Emergomyces, Histoplasma, Blastomyces, and Candida auris represent growing fungal threats with diverse clinical impacts.
- Socioeconomic factors and the COVID-19 pandemic may influence the changing landscape of invasive fungal diseases.
Conclusions:
- Urgent need for improved diagnostics, accessible treatments, and antifungal stewardship in Africa.
- Addressing underlying factors like HIV and healthcare access is crucial for controlling fungal infections.
- Further research is required to develop novel therapies and refine public health strategies against emerging fungal diseases.
More Related Videos
08:48Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
06:58Author Spotlight: Evaluation of Entomopathogenic Fungi in Wild Monochamus alternatus Populations for Biocontrol Applications in Forest Wood Borers
Published on: September 29, 2023
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Fungal Phylum Basidiomycota
Threats to Biodiversity
Overview of Fungi